If you've ever wanted to integrate OpenAI's ChatGPT features into your Java programs, you'll be happy to learn that Spring AI has made the process easier than ever. And it's not just easier to connect ...

D.C. police have arrested two suspects in the gruesome killing of a man in February who was found bound, beaten, strangled and burned inside his condo in the city’s upscale Logan Circle neighborhood ...

Circle shares fell 20% as investors reacted to the latest version of a bill known as the Clarity Act. The proposed legislation could ban stablecoin issuers from paying yield to customers just for ...

Circle, the company behind the $61 billion stablecoin USDC, made a roaring debut on the New York Stock Exchange Thursday, becoming the first stablecoin issuer to go public and making CEO and cofounder ...

Circle’s USD Coin is gaining momentum as a digital alternative to real U.S. dollars. It has plenty of room to grow, but it probably isn’t a millionaire-maker stock. Circle's USD Coin, a cryptocurrency ...

Image source: Getty Images. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...